Amicus Therapeutics Competitors and Similar CompaniesClear all
Amicus Therapeutics's competitors and similar companies include PhaseBio Pharmaceuticals.
 Amicus Therapeutics Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases. |  PhaseBio Pharmaceuticals PhaseBio Pharmaceuticals is a biopharmaceutical company committed to developing new and improved drugs, with an initial focus on endocrine and metabolic disorders and cardiovascular disease. | |
Founding Date | Founding Date 2002 | Founding Date 2002 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Philadelphia, US HQ Northbridge, AU Pointe Claire, CA Paris, FR München, DE Dublin, IE Milano, IT see more | Locations Malvern, US HQ |
Employees | Employees 58415% increase | Employees 22 |
Valuation ($) | Valuation ($) 3.4 b | Valuation ($) N/A |
Financial | ||
Revenue (est.) | Revenue (est.) $634.2m (FY, 2025) | Revenue (est.) $10.8m (FY, 2021) |
Net income | Net income ($27.1m) (FY, 2025) | Net income ($131.1m) (FY, 2021) |
For sources of this data, please see the company profile
View Company Profiles
PhaseBio Pharmaceuticals
HQ
Malvern, US
Employees
22
PhaseBio Pharmaceuticals is a biopharmaceutical company committed to developing new and improved drugs, with an initial focus on endocrine and metabolic disorders and cardiovascular disease.
View company